A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome

Mahesh Swaminathan, Hagop M. Kantarjian, Mark Levis, Veronica Guerra, Gautam Borthakur, Yesid Alvarado, Courtney D. DiNardo, Tapan Kadia, Guillermo Garcia-Manero, Maro Ohanian, Naval Daver, Marina Konopleva, Naveen Pemmaraju, Alessandra Ferrajol, Michael Andreeff, Nitin Jain, Zeev Estrov, Elias J. Jabbour, William G. Wierda, Sherry PierceMaria Rhona Pinsoy, Lianchun Xiao, Farhad Ravandi, Jorge E. Cortes

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)2121-2130
Number of pages10
JournalHaematologica
Volume106
Issue number8
DOIs
StatePublished - Aug 2021

ASJC Scopus subject areas

  • Hematology

Fingerprint

Dive into the research topics of 'A phase I/II study of the combination of quizartinib with azacitidine or low-dose cytarabine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome'. Together they form a unique fingerprint.

Cite this